1801 - 1810 of 6568 Results
Title
Year
-
OPENTitle: The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cellsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 11Start Page: e0259903End Page: e0259903Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0259903Best OA location URL: https://doi.org/10.1371/journal.pone.0259903Citation Count: 22
-
OPENTitle: Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian CohortsJournal Name: Journal of Clinical MedicinePublisher: MDPI AGVol: 10Issue #: 21Start Page: 5085End Page: 5085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jcm10215085Best OA location URL: https://www.mdpi.com/2077-0383/10/21/5085/pdf?version=1635753758Citation Count: 14
-
OPENTitle: Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult miceJournal Name: Transgenic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page: 867End Page: 873Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11248-021-00286-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11248-021-00286-3.pdfCitation Count: 4
-
OPENTitle: COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001104Best OA location URL: https://nn.neurology.org/content/nnn/9/1/e1104.full.pdfCitation Count: 38
-
OPENTitle: Structural basis of polyamine transport by human ATP13A2 (PARK9)Journal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 22Start Page: 4635End Page: 4649.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017Best OA location URL: https://escholarship.org/content/qt0vq3x5sc/qt0vq3x5sc.pdfCitation Count: 49
-
OPENTitle: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 754016End Page: 754016Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.754016Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.754016/pdfCitation Count: 18
-
OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 705407End Page: 705407Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 86
-
OPENTitle: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 94End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00239-xBest OA location URL: https://www.nature.com/articles/s41531-021-00239-x.pdfCitation Count: 53
-
OPENTitle: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomesJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 149End Page: 149Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00513-5Best OA location URL: https://www.nature.com/articles/s41746-021-00513-5.pdfCitation Count: 107
-
OPENTitle: Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 723476End Page: 723476Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.723476Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.723476/pdfCitation Count: 7